Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP054: High-throughput sequencing of T cell receptors from pediatric ulcerative colitis patients reveals distinct tissue-specific repertoiresECCO '17 Barcelona
Year: 2017
Authors:

Werner L.1, Nunberg M.1, Haberman Y.1, Lahad A.1, Turner D.2, Weiss B.1, Shouval D.*1

1Safra Children's Hospital, Department of Pediatric Gastroenterology, Tel Hashomer, Israel 2Shaare Zedak Medical Center, Jerusalem, Israel

DOP055: Results of the Fifth Scientific Workshop of the ECCO (II): clinical aspects of perianal fistulising Crohn's disease – the unmet needsECCO '17 Barcelona
Year: 2017
Authors:

Gecse K.*1, Sebastian S.2, De Hertogh G.3, Yassin N.4, Kotze P.5, Reinisch W.6, Spinelli A.7, Koutroubakis I.8, Katsanos K.9, Hart A.10, van den Brink G.11, Rogler G.12, Bemelman W.13

1Semmelweis University, First Department of Medicine, Budapest, Hungary 2Hull & East Yorkshire NHS Trust, Inflammatory Bowel Disease Unit, Hull, United Kingdom 3University of Leuven, Department of Pathology, Leuven, Belgium 4St Mark's Hospital and Academic Institute, Department of Colorectal Surgery, London, United Kingdom 5Catholic University of Paraná, Colorectal Surgery Unit, Curitiba, Brazil 6Medical University of Vienna, Department of Gastroenterology, Vienna, Austria 7Humanities University, Colorectal Surgery Unit, Humanitas Research Hospital, Milano, Italy 8University Hospital Heraklion, Department of Gastroenterology, Heraklion, Greece 9School of Health Sciences, Division of Gastroenterology, Department of Medicine, Ioannia, Greece 10St. Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom 11Academic Medical Centre, University of Amsterdam, Department of Gastroenterology, Amsterdam, Netherlands 12University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland 13Academic Medical Centre, University of Amsterdam, Department of Surgery, Amsterdam, Netherlands

DOP056: Pathophysiology of perianal fistulising diseaseECCO '17 Barcelona
Year: 2017
Authors:

Siegmund B.1, Feakins R.M.2, Barmias G.3, Coelho Ludvig J.4, Vieira Teixeira F.5, Rogler G.6, Scharl M.*7

1Charite Berlin, Berlin, Germany 2Royal London Hospital, London, United Kingdom 3Ethnikon and Kapodistriakon University of Athens, Athens, Greece 4Santa Isabel Hospital Blumenau, Santa Catarina, Brazil 5Gastrosaude Clinic, Sao Paulo, Brazil 6University Hospital Zürich, Zürich, Switzerland 7University Hospital Zürich, Division of Gastroenterology and Hepatology, Zürich, Switzerland

DOP057: Perianal pediatric Crohn's disease is associated with a distinct phenotype and greater inflammatory burdenECCO '17 Barcelona
Year: 2017
Authors:

Assa A.*1, Amitai M.2, Greer M.-L.3, Castro D.3, Cytter Kuint R.4, Martínez-Leόn M.5, Herman-Sucharska I.6, Coppenrath E.7, Anupindi S.8, Towbin A.9, Moote D.10, Konen O.11, Pratt L.-T.12, Grifitths A.3, Turner D.4

1Schneider Children's Medical Center, Gastroenterology, Nutrition and Liver Diseases, Petach Tikva, Israel 2Sheba Medical Center, Department of Radiology, Ramat Gan, Israel 3Hospital for Sick Children, Toronto, Canada 4Shaare Zedek Medical Center, Jerusalem, Israel 5Hospital Regional Universitario Carlos Haya, Malaga, Spain 6Jagiellonian University in Cracow, Cracow, Poland 7University of Munich, Munich, Germany 8The Children's Hospital of Philadelphia, Philadelphia, United States 9Cincinnati Children's Hospital, Cincinnati, United States 10Connecticut Children's Medical Center, Hartford, United States 11Schneider Children's medical Center, Petach Tikva, Israel 12Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel

DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease?ECCO '17 Barcelona
Year: 2017
Authors:

Laureti S., Coscia M., Gentilini L., Gionchetti P., Renzi N., Rizzello F., Tanzanu M., Poggioli G.

University of Bologna, Department of Gastroenterology and Surgical Sciences, Bologna, Italy

DOP059: New human gut xenograft mouse model for intestinal fistulasECCO '17 Barcelona
Year: 2017
Authors:

Bruckner R.S.*1,2, Marsiano N.3, Nissim-Eliraz E.3, Nir E.3, Lang S.1,2, Spalinger M.1,2, Rogler G.1,4, Yagel S.5, Scharl M.1,4, Shpigel N.Y.3 SysmedIBD EU Research Consortium

1University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland 2University of Zurich, Zurich, Switzerland 3Hebrew University of Jerusalem, Koret School of Veterinary Medicine, Rehovot, Israel 4University of Zurich, Zurich Center for Integrative Human Physiology, Zurich, Switzerland 5Hadassah University Hospital, Obstetrics and Gynecology, Jerusalem, Israel

DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn's disease and ulcerative colitis in the United StatesECCO '17 Barcelona
Year: 2017
Authors:

Siegel C.*1, Yang F.2, Eslava S.2, Cai J.2

1Dartmouth-Hitchcock Medical Center, Lebanon, United States 2Celgene Corporation, Summit, United States

DOP061: Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety resultsECCO '17 Barcelona
Year: 2017
Authors:

Kim Y.H.*1, Ye B.D.2, Pesegova M.3, Alexeeva O.4, Osipenko M.5, Lahat A.6, Dorofeyev A.7, Salamon A.8, Fishman S.9, Levchenko O.10, Cheon J.H.11, Scribano M.L.12, Mateescu R.-B.13, Lee K.M.14, Eun C.S.15, Lee S.J.16, Lee S.Y.16

1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea 2University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea 3Krasnoyarsk Regional clinical hospital, Krasnoyarsk, Russian Federation 4Nizhny Novgorod Regional Clinical Hospital n.a. N.A.Semashko, Nizhny Novgorod, Russian Federation 5Novosibirsk State Medical University, Novosibirsk, Russian Federation 6Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel and Sackler Faculty of Medicine, Tel Aviv University, Ramat-Gan, Israel 7Medical Center LLC Ukrainian German Antiulcer Gastroenterology Center BIK Kyiv, Kyiv, Ukraine 8Tolna Megyei Balassa János Kόrház, Szekszárd, Hungary 9Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10Municipal Institution Odesa Regional Clinical Hospital, Odesa, Ukraine 11Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea 12Azienda Ospedaliera San Camillo Forlanini, Roma, Italy 13Gastroenterology Dept. at Colentina Clinical Hospital AND “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania 14St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea 15Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, South Korea 16CELLTRION, Inc., Incheon, South Korea

DOP062: Biosimilar infliximab (CT-P13) is not inferior to originator infliximab: explorative IBD subgroup-analyses in Crohn's disease and ulcerative colitis from the NOR-SWITCH trialECCO '17 Barcelona
Year: 2017
Authors:

Jørgensen K.K.*1, Olsen I.C.2, Goll G.L.2, Lorentzen M.3, Bolstad N.4, Berset I.P.5, Haavardsholm E.A.2,6, Lundin K.E.6,7,8, Mørk C.9, Kvien T.K.2,6, Jahnsen J.1,6 and the Nor-Switch Study Group

1Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway 2Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway 3Oslo University Hospital, Rikshospitalet, Department of Dermatology, Oslo, Norway 4Oslo University Hospital, Radiumhospitalet, Department of Medical Biochemistry, Oslo, Norway 5Ålesund Hospital, Department of Gastroenterology, Ålesund, Norway 6University of Oslo, Faculty of Medicine, Oslo, Norway 7Oslo University Hospital, Rikshospitalet, Department of Gastroenterology, Oslo, Norway 8Centre for Immune Regulation, Department of Immunology, Oslo, Norway 9Norwegian University of Science and Technology, Faculty of Medicine, Trondheim, Norway

DOP063: Serial tuberculin skin test improves the detection of latent tuberculosis infection in inflammatory bowel disease patientsECCO '17 Barcelona
Year: 2017
Authors:

Taxonera C.*1, Ponferrada A.2, Bermejo F.3, Gisbert J.P.4, Riestra S.5, Saro C.6, Cabriada J.L.7, Barreiro-de Acosta M.8, Barrio J.9, Flores E.10, Ferrer I.11, Hernandez A.12, Van Domselaar M.13, Olivares D.1, Alba C.1, Fernández-Salazar L.14, Merino O.15, Botella B.16, Ceballos D.17, Moral I.18, Peñate M.19, Algaba A.3 on behalf of the SEGURTB Study Group from GETECCU

1Hospital Clinico San Carlos, IdISSC, Madrid, Spain 2Hospital Infanta Leonor, Madrid, Spain 3Hospital de Fuenlabrada, Madrid, Spain 4Hospital Universitario de La Princesa, CIBERehd, Madrid, Spain 5Hospital Central De Asturias, Oviedo, Spain 6Hospital De Cabueñes, Gijόn, Spain 7Hospital San Eloy, Baracaldo, Spain 8Hospital de Santiago De Compostela, Santiago de Compostela, Spain 9Hospital Río Hortega, Valladolid, Spain 10Hospital Universitario Reina Sofía, CIBERehd, Cόrdoba, Spain 11Hospital de Manises, Manises, Spain 12Hospital Universitario De Canarias, Santa Cruz De Tenerife, Spain 13Hospital de Torrejόn, Madrid, Spain 14Hospital Clinico de Valladolid, Valladolid, Spain 15Hospital De Cruces, Bilbao, Spain 16Hospital Universitario Infanta Cristina, Madrid, Spain 17Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain 18Hospital Príncipe De Asturias, Madrid, Spain 19Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain

DOP064: High rate of advanced neoplasia after detection of low-grade dysplasia in inflammatory bowel disease patients with primary sclerosing cholangitisECCO '17 Barcelona
Year: 2017
Authors:

Ten Hove J.R.*1, Torres J.2, Castaneda D.2, Palmela C.2, Mooiweer E.1, Shah S.C.2, Colombel J.-F.2, Ullman T.2, Itzkowitz S.H.2, Oldenburg B.1

1University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands 2Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology, New York, United States

DOP065: Use of chromoendoscopy versus white light endoscopy for colorectal cancer surveillance in inflammatory bowel disease patients with primary sclerosing cholangitis; a six year experienceECCO '17 Barcelona
Year: 2017
Authors:

Hartery K., Williamson K., Chapman R., Atkinson N., East J.

John Radcliffe Hospital, Translation Gastroenterology Unit, Oxford, United Kingdom

DOP066: Strict surveillance colonoscopy should be performed for the ulcerative colitis patients who underwent ileorectal anastomosisECCO '17 Barcelona
Year: 2017
Authors:

Anzai H., Hata K., Ishihara S., Kishikawa J., Murono K., Kaneko M., Sasaki K., Yasuda K., Otani K., Nishikawa T., Tanaka T., Kiyomatsu T., Kawai K., Nozawa H., Watanabe T.

The University of Tokyo, Department of Surgery, Tokyo, Japan

DOP067: Risk of malignant and non-malignant complications of the rectal stump in patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Bogaerts J.*1, Ten Hove J.R.1, Laclé M.M.2, Meij V.3, Oldenburg B.1

1University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands 2University Medical Center Utrecht, Department of Pathology, Utrecht, Netherlands 3University Medical Center Utrecht, Department of Surgery, Utrecht, Netherlands

DOP068: The virtual electronic chromoendoscopy score in ulcerative colitis exhibits very good inter-rater agreement in scoring mucosal and vascular changes after computerised module training: a study across academic and community practiceECCO '17 Barcelona
Year: 2017
Authors:

Trivedi P.*1,2,3,4, Hodson J.3, Bhala N.4, Cooney R.4, Boulton R.4, Gui X.5, Iqbal T.4, Li K.-k.6, Mumtaz S.7, Pathmakanthan S.4, Quraishi M.N.4, Sagar V.M.1, Shah A.7, Sharma N.8, Siau K.7, Smith S.4, Ward S.9, Widlak M.M.10,11, Ghosh S.3,4, Iacucci M.3,4

1University of Birmingham, NIHR Birmingham Liver Biomedical Research Unit, Birmingham, United Kingdom 2Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom 3University of Birmingham, Institute of Translational Medicine, Birmingham, United Kingdom 4Queen Elizabeth Hospital, Department of Gastroenterology, Birmingham, United Kingdom 5University of Calgary and Calgary Laboratory Services, Department of Pathology and Laboratory Medicine, Calgary, Canada 6Leicester Royal Infirmary, Department of Gastroenterology and Hepatology, Leicester, United Kingdom 7New Cross Hospital, Department of Gastroenterology, Wolverhampton, United Kingdom 8University Hospitals Birmingham Heart of England Foundation Trust, Department of Gastroenterology, Birmingham, United Kingdom 9University Hospitals Coventry and Warwickshire, Department of Colorectal Surgery, Coventry, United Kingdom 10University Hospitals Coventry and Warwickshire, Department of Gastroenterology, Coventry, United Kingdom 11University of Warwick, Warwick Medical School, Coventry, United Kingdom

DOP069: Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centersECCO '17 Barcelona
Year: 2017
Authors:

Cremer A.*1, Liefferinckx C.1, De Vos M.2, Rahier J.-F.3, Baert F.4, Moreels T.5, Macken E.5, Louis E.6, Devière J.1, Van Gossum A.1, Vermeire S.7, Franchimont D.1

1University Hospital Erasme, Gastroenterology, Brussels, Belgium 2University Hospital Gent, Gastroenterology, Brussels, Belgium 3University Hospital Mont-Godinne, Gastroenterology, Yvoir, Belgium 4AZ Delta, Roeselare, Belgium 5University Hospital Antwerp, Edegem, Belgium 6University Hospital Liège, Liège, Belgium 7University Hospital Leuven, Gastroenterology, Leuven, Belgium

DOP070: Endoscopic response to induction therapy with TNF inhibitors is the best predictor of long term mucosal healing in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Alfaro I.*1, Masamunt M.1, Planell N.2, Lόpez-García A.1, Castro J.1, Gallego M.1, Barastegui R.1, Giner A.1, Vara A.1, Salas A.2, Ricart E.1, Panés J.1, Ordás I.1

1Hospital Clínic, Gastrointestinal Disease, Barcelona, Spain 2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

DOP071: Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohn's disease: a sub-analysis of DIAMOND trialECCO '17 Barcelona
Year: 2017
Authors:

Watanabe K.*1, Matsumoto T.2, Motoya S.3, Hisamatsu T.4, Nakase H.5, Yoshimura N.6, Ishida T.7, Kato S.8, Nakagawa T.9, Nagahori M.10, Esaki M.11, Matsui T.12, Naito Y.13, Kanai T.14, Suzuki Y.15, Nojima M.16, Watanabe M.10, Hibi T.17

1Osaka City General Hospital, Gastroenterology, Osaka, Japan 2Iwate Medical University, Division of Gastroenterology, Department of Medicine, Morioka, Japan 3Sapporo Kosei General Hospital, Inflammatory Bowel Disease Centre, Sapporo, Japan 4Kyorin University School of Medicine, Department of Internal Medicine, Tokyo, Japan 5School of Medicine, Sapporo Medical University, Department of Gastroenterology and Hepatology, Sapporo, Japan 6Tokyo Yamate Medical Centre, Department of Medicine, Division of Gastroenterology, Tokyo, Japan 7Oita Red Cross Hospital, Department of Gastroenterology, Oita, Japan 8Saitama Medical Centre, Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe, Japan 9Graduate School of Medicine, Chiba University, Department of Gastroenterology and Nephrology, Chiba, Japan 10Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan 11Graduate School of Medical Sciences, Kyushu University, Department of Medicine and Clinical Science, Fukuoka, Japan 12Fukuoka University Chikushi Hospital, Department of Gastroenterology, Fukuoka, Japan 13Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology, Kyoto, Japan 14School of Medicine, Keio University, Department of Internal Medicine, Tokyo, Japan 15Toho University Sakura Medical Center, Department of Internal Medicin, Chiba, Japan 16Institute of Medical Science Hospital, University of Tokyo, Centre for Translational Research, Tokyo, Japan 17Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan

DOP072: Assessment of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) using central video review of colonoscopies in paediatric patients with ulcerative colitis: data from the Canadian Children IBD NetworkECCO '17 Barcelona
Year: 2017
Authors:

Carman N.*1, Huynh H.2, Mouzaki M.3, Crowley E.3, Walsh C.M.3, Ricciuto A.3, Walters T.D.3, Church P.C.3

1The Hospital for Sick Children, Toronto, Canada 2University of Alberta, Edmonton, Canada 3The Hospital for Sick Children, University of Toronto, Gastroenterology Department, Toronto, Canada

DOP073: Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe diseaseECCO '17 Barcelona
Year: 2017
Authors:

Atreya R.*1, Kühbacher T.2,3, Waldner M.J.1, Hirschmann S.1, Drvarov O.2, Abu Hashem R.2, Maaser C.4, Kucharzik T.4, Dinter J.5, Schramm C.5, Mertens J.5, Holler B.6, Mössner J.6, Suzuki K.7, Yokoyama J.7, Terai S.7, Yoneyama H.8, Asakura H.7, Hibi T.9, Neurath M.F.1

1Friedrich-Alexander University Erlangen-Nürnberg, Department of Medicine I, Erlangen, Germany 2Asklepios Westklinikum, Department of Internal Medicine/Gastroenterology, Hamburg, Germany 3Christian Albrechts University Kiel, Department of Internal Medicine/Gastroenterology, Kiel, Germany 4Klinikum Lüneburg, Klinik für Allgemeine Innere Medizin und Gastroenterologie, Lüneburg, Germany 5Uniklinik Köln, Klinik für Gastroenterologie und Hepatologie, Köln, Germany 6Universitätsklinikum Leipzig, Klinik und Poliklinik für Gastroenterologie und Rheumatologie, Leipzig, Germany 7Niigata University Medical and Dental Hospital, Niigata, Japan 8Stelic Institute & Co., Tokyo, Japan 9Kitasato University, Center for Advanced IBD Research and Treatment, Tokyo, Japan